Clinical trial
Biomarker Prediction Through Deep Learning Approaches From Histopathological Whole Slide Images in Early Breast Cancer
NCT07842068 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker Prediction Through Deep Learning Approaches From Histopathological Whole Slide Images in Early Breast Cancer
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 10, 1996
- Completion date
- July 23, 2026
- Enrollment
- 3,648 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
early breast cancer